bioAffinity Technologies gets Japan patent allowance for CyPath Lung
The company said the Japan Patent Office issued a Notice of Allowance for its CyPath Lung AI-powered method to predict early-stage lung cancer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results.
bioAffinity Technologies gets Japanese patent allowance notice
bioAffinity Technologies said the Japan Patent Office issued a notice of allowance for a patent covering its CyPath Lung method for predicting the likelihood of lung cancer. The company said the patent would add to its intellectual property portfolio in Asia once the issuance fee is paid.
bioAffinity Technologies gets Japan patent allowance for CyPath Lung AI
bioAffinity Technologies said Japan issued a Notice of Allowance for a patent covering its noninvasive CyPath Lung test and AI-built algorithm for early-stage lung cancer detection, with issuance expected after payment of the fee.
bioAffinity Technologies gets Japan patent allowance for CyPath lung algorithm
bioAffinity Technologies said Japan Patent Office issued a Notice of Allowance for patents covering its noninvasive CyPath lung testing and an AI-built algorithm.